Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma
Academic radiology(2023)
摘要
•The prognosis of HCC patients with PVTT is poor, and PVTT is the factor limiting current treatment.•125I brachytherapy has a high LTCR in HCC patients with PVTT.•Patients aged <60 years, with type I+II PVTT, and with a tumor diameter <5 cm have a more favorable OS.•125I brachytherapy is safe for treating PVTT of HCC.
更多查看译文
关键词
Hepatocellular carcinoma,Portal vein tumor thrombus,Iodine-125,local tumor control rate
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要